跳至主要内容
临床试验/IRCT20240116060710N1
IRCT20240116060710N1招募中3 期

Evaluation the effect of Botulinum toxin type A Masport 500 injection on improving pain and quality of life in patients with diabetic neuropathy.

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Definite diabetic neuropathy in the plantar area of ??both feet confirmed by NCV.
  • diabetes at least for three years
  • Consistency of the patient's medication for diabetic neuropathy for at least one month before entering the study
  • Filling out a personal consent form to enter the study

排除标准

  • Having an underlying disease involving the peripheral nerves that causes symptoms similar to diabetic neuropathy in the plantar area.
  • Change in the patient's medication for diabetic neuropathy during at least one month before entering the study
  • History of myasthenia gravis
  • Allergy to botulinum toxin
  • kidney dysfunction
  • Having a history of alcohol consumption
  • Opioid addiction
  • Presence of pain with a typical dermatomal pattern caused by radiculopathy
  • Lack of patient consent to participate in the study

研究者

相似试验

Evaluation the effect of Botulinium toxin injection... | 临床试验